ACE Report Cover
Remimazolam vs Propofol for Hemodynamic Stability in Prone Spine Surgery
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
SPINE
Remimazolam vs Propofol for Hemodynamic Stability in Prone Spine Surgery .

Effect of Remimazolam- versus Propofol-Based Total Intravenous General Anesthesia on Intraoperative Hemodynamic Stability for Major Spine Surgery in the Prone Position: A Randomized Controlled Trial.

Medicina (Kaunas) . 2024 Mar 5;60(3):432.
Contributing Authors

HJ Kim JY Kim HS Park H Kim YJ Ro WU Koh

Ninety-four patients undergoing major spinal surgery in the prone position were randomized to receive either remimazolam-based total intravenous anesthesia (TIVA) (n=47) or propofol-based TIVA (n=47). The primary outcome was the incidence of hypotension during the first hour after prone positioning. Secondary outcomes included incidence of severe hypotension, number of hypotensive episodes per patient, and total amount of vasopressors administered. Hemodynamic variables such as mean arterial pressure (MAP), heart rate, stroke volume, and cardiac output were monitored continuously. Overall, the results of the study revealed no significant difference in the incidence of hypotension or severe hypotension between groups. However, the remimazolam group had higher MAP in the initial 10 minutes post-positioning and required less ephedrine. These findings suggest remimazolam may offer marginal hemodynamic benefits in the immediate post-positioning period.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Remimazolam vs Propofol for Hemodynamic Stability in Prone Spine Surgery. ACE Report. 2025;307(6):58. Available from: https://myorthoevidence.com/AceReport/Show/remimazolam-vs-propofol-for-hemodynamic-stability-in-prone-spine-surgery

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report